chrisvoncsefalvay/vaers-outcomes huggingface dataset:
presented to ED with hypoxia, cough, SOB, chills, loss of taste and smell, loose stools; hx of HTN; tested positive for COVID-19; acute chronic kidney disease; pt deteriorated during the hospital stay and eventually passed away in the hospital; COVID-19 pneumonia
Mild headache and nausea set in shortly after the injection on Friday, but went away after rest and eating/drinking. My arm was sore for the entire evening. I woke up around 2am Saturday morning and became dizzy. I fell to the floor and passed out for a short period of time. When I woke, I was extremely nauseous to the point of nearly vomiting. I had chills and fever. I could hardly move due to weakness - I needed help getting back into bed. When I woke the next morning, I had 100.3 fever, I had a headache and my entire body was sore. My fever went away late Saturday afternoon, but I still felt mildly nauseous. It is Monday and I still have mild nausea and light-headedness. My arm is only slightly sore.
Patient fainted 2 minuets after vaccination. Patient then slipped off chair and regained consciousness in about 10 seconds
LOC after vaccine administered. Caught  by MA pt did not hit head. Brought to exam table and leveled pt lupine LOC about 30 seconds total. After 30 seconds pt responsive, pale. BP=100/62; P=68 states never fainted with vaccine previously.
slight headache productive cough stuffy nose heart palpitations trouble falling asleep/restlessness
Subject was a marathon runner.  She experienced knee issues after she returned from deployment.  X-ray revealed rapid bone deterioration.  She had R hip replacement 1-2 years ago.  Previous doses of anthrax vaccines received February 14, 2003, February 27, 2003, March 13, 2003, August 10, 2003.
pt recvd vax 17MAY91 & p/vax devel fever of 102.5 & dyspnea; fever persisted for 3 to 4 days then remitted; later recovered; no further details;
Case received primary 2 doses of coivid vaccine by Feb. 2021, then was hospitalized for Covid in January 2022. Hospitalized at: (Privacy).    * Pneumonia due to COVID-19 virus Assessment & Plan Presented with increased somnolence and confusion one day after testing positive for covid at facility. She was mildly hypoxic on arrival although CXR showed no infiltrates. She received two doses of Pfizer vaccine last winter but it appears she missed her booster shot due to her recent injuries and hospitalizations. Her O2 needs during admission have been variable, although she is currently on room air.  - Finished dexamethasone x10 days, last day 1/29 - Finished remdesivir x5 days, last day 1/24       Acute respiratory failure with hypoxia (HCC) Assessment & Plan Due to covid pneumonia. At time of admit was 87% on RA, crackly, rhonchorous - see notes there
Covid test result: Positive; This is a spontaneous report from a contactable consumer or other non-HCP. A 34-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in Left Arm on 24Mar2021 11:00 as DOSE 1, SINGLE (at the age of: 34-year-old) for covid-19 immunization . Medical history included contraception. Concomitant medication(s) included spironolactone (SPIRONOLACTONE); drospirenone, ethinylestradiol (SYEDA) taken for contraception. No other vaccine in four weeks. Other medications in two weeks mentioned as Spironolactone and Syeda for birth control. The patient had not diagnosed with covid prior vaccination. And post vaccination, patient had tested with covid 19 via Nasal swab test on 31Mar2021. No known allergies and Other medical history reported for the patient. On 31Mar2021, the patient experienced covid test result: positive. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 31Mar2021. No treatment was given for the reported events. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Systemic: pt said he's now having phobias and suspicions and other symptoms but would not clarify further-Severe, Additional Details: Pt was very angry when he called on 4/3/23 and said after he received the vaccine on 6/18/2022 he went home and took a nap and after he woke up is when the symptoms began and they have continued since then. He said his symptoms include phobias and being suspicious. He said there are other symptoms, but when I asked for more details he said no.
Reaction:  15mins post vaccination Pt self reported hives after both Pfizer doses and chest tightness after dose 2.  Pt reports that hives started 10-15 mins post vaccination in both cases.  For Dose 2 pt premedicated w/ benadryl but still developed hives.
This case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a 70-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included ZOSTAVAX (administered a few years before the reporting date). On 24th June 2018, the patient received the 1st dose of SHINGRIX. On 1st August 2018, 38 days after receiving SHINGRIX, the patient experienced feeling unwell. On 3rd August 2018, the patient experienced rash. The patient was treated with valaciclovir hydrochloride (Valtrex) and prednisone. On an unknown date, the outcome of the feeling unwell was recovering/resolving and the outcome of the rash was not recovered/not resolved. It was unknown if the reporter considered the feeling unwell and rash to be related to SHINGRIX. Additional information was reported as follows: The patient did not have any history of shingles. About a week and a half before the reporting date, the patient received vaccine in the left arm. In the previous week of reporting, she did not feel good, but not sure if that was related. On Friday, the patient began to develop rash and bumps from her chin up on the right side of her face. The patient also experienced eruption on the right eye lid. The patient went to an urgent care a day before the date of reporting, and was treated for Shingles with Valtrex and Prednisone at the reporting time. She noted the bumps did not appear to be blisters and only the eye one looked like it could had been however it was better after beginning Valtrex. The contact details of the urgent care physician was provided. The patient declined primary care provider (PCP) information, as he had not been made aware, and she noted she was being treated so she did not believe a need to let him know or to see him.
Abdominal pain.  Across my entire abdomen.   I took each pill later in the day.  The next morning I woke up in pain that lasted all day.  It felt like my internal organs were being slowly enzymatically digested.  There was also a little cramping. The pain would oscillate in terms of severity every few hours. It would finally subside right before it was time for me to take the next pill.  I completely lost my appetite for that week, but forced myself to eat semi-regular meals.  It affected my work; students kept asking if I was OK.    In terms of taking the vaccine as directed, the timing was appropriate, including taking on an empty stomach.  But I did not drink as much water as directed when taking each pill.  I would say I drank just half a cup of water with each pill.  Lastly, a week later I went back to the travel clinic for a different vaccine, and informed the doctor of the side effects.  She assured me this is not uncommon, and nothing to be concerned about since the symptoms have subsided.
pt recv vax & exp burning localized reaction (sl erythematous warm rash);sx resolved w/in 24hr;
This case was reported by a physician via sales rep and described the occurrence of pain in arm in a 19-year-old female patient who received BEXSERO. On 14th July 2016, the patient received the 1st dose of BEXSERO (intramuscular) .5 ml. In July 2016, less than a month after receiving BEXSERO, the patient experienced pain in arm (serious criteria disability) and mobility decreased (serious criteria disability). On an unknown date, the outcome of the pain in arm and mobility decreased were not recovered/not resolved. It was unknown if the reporter considered the pain in arm and mobility decreased to be related to BEXSERO. Additional details were received as follows: The reporter stated to the sales representative that the patient had no issues with previous vaccines. The injection site for BEXSERO was unknown. The patient experienced arm pain and it was hard for the patient to move her arm. Limited information was provided by the sales representative from the physician. The date of onset of the event was unknown.
Initial case received from a health care professional on 05 October 2009. This case pertains to a cluster of four patients who experienced adverse reactions following receipt of FLUZONE 2009-2010. No individual identifiers were provided, and so all four patients are included in this case. Four patients experienced fever, malaise, sweating, and chills after receiving intramuscular injections of FLUZONE 2009-2010 (lot number U3173AA) individual dates not reported). All patients reported experiencing fever, general malaise, sweating, and chills the night of vaccination. One patient also had numbness in his arm which radiated to the back. Another patient reported muscular aches and pains two days post-vaccination, with an elevated CPK of approximately 900. Three of the four patients never had received influenza vaccines prior to this administration. Per the reporter, all of the events had resolved. Follow-up information was received from the health care professional on 09 November 2009, and provided identifying information for each of the four patients. This case now contains information for one patient; the other three cases are non-serious, and are captured in 2009-04795, 2009-04808, and 2009-04809. A 43-year-old male patient, with no reported medical history, received an intramuscular injection of FLUZONE 2009-2010 (lot number U3173AA) on 23 September 2009. In addition to fever, general malaise, sweating, and chills the night of vaccination, the patient also experienced muscular aches and pains on 25 September 2009. Laboratory testing performed on 29 September 2009 showed a CPK of 924 IU/L. Granulocytes were low at 39.6%. Additional testing, including a CBC with differential, sedimentation rate, and comprehensive metabolic panel, was normal. The patient recovered. Documents held by sender: None.
I was standing in the hallway at the copy machine at work, talking to someone else making copies and waiting for his job to finish. I became so dizzy that I put my hand out to brace myself against the wall. The dizziness passed quickly and has not returned. But at that moment it was so bad I thought I would faint. But I didn?t.
pharmacist gave vaccine too low, patient complain today 3/11 of severe pain in arm, she had a bruise where the shot was given. recommended drinking plenty of water and ice pack
After giving the vaccine , the patient seemed fine and we chatted, upon entering the pharmacy I noticed he passed out, slumping to his right in the chair.  I tapped him on the shoulder and he woke up.   After figuring out where he was he was fine within 60 seconds.  we had called an ambulance as a precaution and he refused to be transported and refused medical attention
it completely halted one of my autoimmune diseases/Chronic rhinosinusitis with nasal polyps (CRSwNP).; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (BNT162B2 OMI XBB.1.5), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Chronic rhinosinusitis with nasal polyps" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "it completely halted one of my autoimmune diseases/Chronic rhinosinusitis with nasal polyps (CRSwNP).". Additional information: Important: After receiving the Pfizer covid vaccine, it completely halted one of my autoimmune diseases: Chronic rhinosinusitis with nasal polyps (CRSwNP). Daily, I would have rock like polyps forming in my nasal passages that were very painful to remove. This had gone on for a few years. I haven't had one since the vaccine.   Follow-up attempts are completed. No further information is expected.
a lot of headache; Body soreness; This is a spontaneous report from a contactable consumer. This 52-year-old female consumer(patient) reported that received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EW0151, Expiry Date: 31Jul2021) on 09Apr2021 at single dose on right arm for covid-19 immunization. Medical history and concomitant drug were not reported. Patient stated that she received her second dose of the Pfizer BioNTech COVID-19 vaccine on 09Apr2021 and she started experienced symptoms on Monday 12Apr2021 that included "a lot of" headache (Headache was reported as worsened) and "body soreness (body soreness was reported as worsened)." Caller would like to know if there are any medications that she can take to relieve this pain, as she has already taken Tylenol which his not helping. Outcome of the event was not recovered.  No follow-up attempts are needed. No further information is expected.
5 Days after receiving the vaccination, I experienced a severe episode of vertigo which required medical treatment at my local hospital. The onset was sudden and severe in nature. I could not walk, stand, or safely perform other normal routine activities. I was diagnosed with BPPV. I followed up with my Primary care doctor. I asked if this could be a possible side effect of the shot that I had just received a few days prior, and was told no. I was wondering if this could be a possible result of an immune response that I was having to the vaccine. I had to live with these very debilitating symptoms for about 1 month. I was prescribed a scopolamine patch to help manage my symptoms for a few days. Eventually this feeling went away after about 1 month. I have never experienced this before this particular flu vaccination, and I have never experienced again. This reaction that I believe to have been associated with the vaccine, and the disregard from providers to even explore if there was a correlation has made me extremely cautious/leery of vaccination processes.
This spontaneous report as received from a Licensed Practical Nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of PEDVAXHIB lot # M001811, expiration date 04-NOV-2018 and lot # reported as M014925, expiration date 16-FEB-2019 (dose and route of administration were not reported). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 12/23/2021 pfizer,Lot# 2nd dose: 01/13/2021,Pfizer,Lot#  Diagnosed covid positive:07/24/21 symptom onset:07/19/21 Exposure:unknown Symptoms:loss of taste, smell,runny nose.
Red and swollen at site-called pharmacy. Instructed to take benadryl and ice. Symptoms continued and itching all over including scalp. Patient went to dr and was precribed medrol dose pack and zyrtec for symptom relief.
Patient received vaccination and was fine until 1-2 minutes later when she had a seizure-like reaction where she was unresponsive for about 90 seconds. Blood pressure was temporarily low 85/55 and patient appeared pale and sweaty for about 15 minutes after the episode.
Information has been received from a physician concerning an 80 year old female with a history of herpes simplex who on 11-MAR-2008 was vaccinated with a dose of zoster vaccine live (Oka/Merck). On approximately 11-MAR-2008 the patient experienced herpes simplex outbreak and lesions around her mouth. The patient called the office today and said that it occurred within the last 24 hours. The patient's herpes simplex outbreak and lesions around her mouth persisted. Unspecified medical attention was sought. No product quality complaint. Additional information has been requested.
pt experienced very low blodd pressure, severe chills, could not sleep.  wife called ambulance and pt. was admitted to local hospital
Improper dilution of vial resulted in 15 microgram dose.  Parent informed of error.
This spontaneous report was received from a healthcare worker via a company representative concerning a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a fourth dose of GARDASIL (lot number, expiry date, dose and route unspecified). The patient received a fourth dose of GARDASIL because the GARDASIL series was restarted due to a 3 year delay after the first dose. No concomitant medications were reported. On an unknown date, the patient developed neck stiffness after receiving the fourth dose of GARDASIL. On an unknown date, the patient recovered and was not hospitalized. The relatedness for neck stiffness was unknown for GARDASIL. Additional information has been requested.
Hives and itching and throat tightness aches and pains.  Pt took BENADRYL immediately to relieve symptoms.
Initial unsolicited report received from a consumer (patient's ex-wife) on 06-Sep-2017. This case involves an 81 year male patient (age also reported as 82 year) who was vaccinated with a dose of FLUZONE HD (Batch number, expiry date, dose, dose in series and site and route of administration were not reported) on 04-Sep-2017 in afternoon. Patient's medical history was reported that pre-existing physician diagnosed allergies, birth defect, medical condition included Diabetes, Hypertension, Hypercholesterolemia, had no known allergies. Illness at the time of vaccination was none. Any other vaccinations within four weeks of vaccinations were none. On 04-Sep-2017 evening, few hours following the vaccination, the patient became very dizzy, and he needed to hold on to the walls to walk. On 05-Sep-2017, one day following vaccination patient was a little dizzy in the morning, and was very gassy all day. 06-Sep-2017, two days following vaccination he was very tired, and he didn't sleep very well. Patient also stated he was not dizzy today. Reporter stated patient was planning on seeing his doctor today. Laboratory investigations were none and corrective treatment were not reported. The outcome of event was reported as unknown. List of documents held by sender: none.
no adverse event; Patient was given Moderna bivalent booster dose one day out of expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was given Moderna bivalent booster dose one day out of expiration date) and NO ADVERSE EVENT (no adverse event) in a 60-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7171B) for COVID-19 prophylaxis. No Medical History information was reported. On 19-Jan-2023, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 19-Jan-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was given Moderna bivalent booster dose one day out of expiration date). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was given Moderna bivalent booster dose one day out of expiration date) and NO ADVERSE EVENT (no adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient was given Moderna bivalent booster dose one day out of expiration date). No concomitant medicine was reported. No treatment medicine was reported.
Pt vaccinated with DTP/HIB developed high pitched cry & fever greater than 18 hrs after DPT
Pt received a shingrix shot, second dose, in the deltoid left arm 11-12-19 approx. 10 AM. Pt left store, called Approx 2 pm complaining of severe soreness + limited movement of left arm. Was told to take an anti inflammatory + alternate heat + ice. Recalled pt at 3 pm stated a little better. Called pts healthcare provider + explained situation. Called pt again around 8:15 pm. Stated still limited movement + pain. Pt contacted pharmacy on 11-13, told to cont ice + change from aleve to ibuprofen. Spoke to patient 11-15-19 at approx. 1 pm says about 85% improved. motion returning to arm. Told him we would follow up again next week.
1.  Patchy hair loss noted two months after second dose (the date provided on this form).  2.  Significant adverse reaction to recent DPAT immunization. No history of vaccination reactions. Chills, nausea, significant swelling of entire outer bicep, swelling over clavicle on injection side, swelling on shoulder blade at day two. Prescribed antibiotics and steroids. Advised to increase Benadryl dosing and use Tylenol. Some clearing of symptoms at Day 4.
Please note, I am listing both shots.  The first dose was received on March 27, 2021.  In early July 2021, I started experiencing a rapid heart beat (over 100bmp) feelings of anxiety, lethargy, shortness of breath, and an inability to concentrate on tasks.  (For a point of reference, my usual resting heart rate is in the low 60s.)  Despite resting I was unable to alleviate the symptoms and went to the emergency room.  At the hospital, I had an elevated heart rate (103) and blood pressure (166/94).  Lab work showed negative troponin and d-dimer.  IV fluids were administered and after 30 minutes, heart rate and blood pressure decreased.  Diagnosis was heart palpitations, chest pain (unspecified type), and premature ventricular contractions.
This spontaneous report as received from a registered nurse and refers to a 47 year old patient of unknown gender. On 08-SEP-2014 the patient was vaccinated with a third dose of RECOMBIVAX HB injection, 10/1.0 mcg/ml,, dose: 1 ml lot # J008505, expiration date: 07-FEB-2016, 1 ml, intramuscular (anatomical location and lot number were not reported) which was improperly stored. The reporter stated that it was the patient's third dose in the series. No adverse effects reported. The reporter also stated that GARDASIL and PNEUMOVAX23 were improperly stored but they were not administered to any patients. Additional information has been requested.
onset fever 4-6 hrs p/vax; episode of turning very pale w/gagging like nauseated; 4 hrs p/vax gagging & fever cont & devel loose stools 1-2 day; 5PM had sz;
Several days after pt had vaccines- was within 2 weeks, she quit breathing and had seizures. Mother informed clinic of this at w/c appt.